Vaccinex Inc. is a clinical-stage immunotherapy company focused on developing targeted biotherapeutics to treat unmet medical needs, including cancer and neurodegenerative diseases. The company is currently conducting clinical trials on Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is utilizing its proprietary drug discovery platform, ActivMAb®, to expand its pipeline and develop high-value antibodies to multi-pass membrane receptors. Based in Rochester, New York, the company is also seeking strategic collaborations to accelerate its drug development efforts.
Vaccinex, Inc.'s ticker is VCNX
The company's shares trade on the NASDAQ stock exchange
They are based in Rochester, New York
There are 11-50 employees working at Vaccinex, Inc.
It is http://www.vaccinex.com/
Vaccinex, Inc. is in the Healthcare sector
Vaccinex, Inc. is in the Biotechnology industry
The following five companies are Vaccinex, Inc.'s industry peers: